title: Combined radioimmunotherapy and radiotherapy of human colon carcinoma grafted in nude mice.
abstract: The effect of combined radioimmunotherapy (RIT) and fractionated external beam radiotherapy (RT) was assessed in two human colon cancer xenografts, Co112 and LS174T in nude mice. These tumors were selected for being resistant to RIT alone, as is usually the case in the clinical situation. Tumor-bearing mice were treated with a combination of five X-ray fractions over 5 days followed by RIT with two doses of 1.5 mCi 131I-labeled anticarcinoembryonic antigen monoclonal antibody F(ab')2. In Co112 and LS174T, RIT alone achieved a regrowth delay similar to that of fractionated RT with total doses of 28 and 26 Gy, respectively. In both tumor types, an additive therapeutic effect, measured as increased regrowth delay or local control, was observed when combining RT of different dose levels with RIT. Normal tissue responses were assessed by monitoring acute peak skin reactions and blood cell count. Bone marrow depression for the combination treatment was similar to that of RIT alone; relative to skin, at equitoxic levels, no mice bearing Co112 tumors were locally controlled with a 32 Gy RT dose alone, while this RT combined with RIT gave a local control of 100%. These studies show a therapeutic benefit when external beam RT is combined with RIT.
authors: Division of Nuclear Medicine, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.
authors: F
authors: F
authors: Buchegger
authors: A
authors: A
authors: Rojas
authors: A B
authors: AB
authors: Delaloye
authors: C A
authors: CA
authors: Vogel
authors: R O
authors: RO
authors: Mirimanoff
authors: P
authors: P
authors: Coucke
authors: L Q
authors: LQ
authors: Sun
authors: S
authors: S
authors: Raimondi
authors: J
authors: J
authors: Denekamp
authors: A
authors: A
authors: Pèlgrin
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D001769:Blood / Q000528:radiation effects; D001853:Bone Marrow / Q000528:radiation effects; D002272:Carcinoembryonic Antigen / Q000276:immunology*; D003110:Colonic Neoplasms / Q000532:radiotherapy*; D003131:Combined Modality Therapy / Q000009:adverse effects; D005260:Female; D006801:Humans; D007457:Iodine Radioisotopes / Q000627:therapeutic use*; D051379:Mice; D008819:Mice, Nude; D009368:Neoplasm Transplantation; D016499:Radioimmunotherapy; D012871:Skin Diseases / Q000209:etiology; D013997:Time Factors; D014183:Transplantation, Heterologous
chemical_list: D000911:Antibodies, Monoclonal; D002272:Carcinoembryonic Antigen; D007457:Iodine Radioisotopes